Company Filing History:
Years Active: 2013
Title: Innovations of Bertrand Sutter: Pioneering Crystal Modifications
Introduction: Bertrand Sutter, an accomplished inventor based in Hésingue, France, has made significant contributions to the field of pharmaceuticals. His innovative work focuses on enhancing drug formulations, particularly in cancer therapy.
Latest Patents: Sutter holds a notable patent for the "Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use." This patent relates to a new crystalline form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-yl-methyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide. This invention shows potential use in tumor therapy, underscoring Sutter's commitment to combatting cancer through innovative medicinal chemistry.
Career Highlights: Sutter's work is closely associated with Novartis AG, a leading global healthcare company. His expertise in developing pharmaceutical formulations has positioned him among the forefront of inventors in the industry, with this patent being a testament to his innovative thinking and scientific prowess.
Collaborations: Throughout his career, Sutter has collaborated with prominent professionals in the field, including Juerg Zimmermann and Hans Michael Buerger. This collaborative spirit has allowed for the exchange of ideas and has further contributed to the successful development of his patent.
Conclusion: Bertrand Sutter's contributions to the field of pharmaceuticals highlight the vital role of innovation in developing effective therapies. His work not only exemplifies a commitment to scientific advancement but also reflects the potential impact that crystal modifications can have on the future of cancer treatment.